Time to be selectively bullish again? 5 small-cap stocks from different sectors with upside potential of up to 29%The conditions that created the worst 18 months for small-caps are starting to ease. The US-Iran war is moving towards settlement. Crude pr...
17 Jun, 2026, 02.18 PM IST
Startup investors cash out nearly Rs 18,000 crore after IPO lock-ins endTop global investors like SoftBank and KKR have cashed out nearly Rs 18,000 cr from new-age Indian companies post-listing. This marks a shi...
16 Jun, 2026, 08.18 PM IST
Will SpaceX's $75 billion IPO set the ball rolling for Reliance Jio and NSE listings in India?SpaceX's massive IPO is making waves globally. However, Indian market experts believe this will not directly impact upcoming listings of Ji...
15 Jun, 2026, 09.55 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
12 Jun, 2026, 12.49 PM IST
A mariner put 10% of her paycheck into SpaceX for 2 years, and as it goes public, she is not telling her net worthMaryellyn Musselman, a former SpaceX mariner, is holding onto her company shares ahead of its highly anticipated IPO. She invested 10% of h...
11 Jun, 2026, 03.53 PM IST
Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
11 Jun, 2026, 09.26 AM IST
ADIA to sell 2.3% Lenskart stake in Rs 1,944 crore block dealAbu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...
10 Jun, 2026, 11.23 PM IST
A new IPO frenzy: Why is Bharat making a beeline for bourses?Retail chains from smaller Indian towns are planning to raise over Rs 7,000 crore through IPOs. These companies see capital markets as a fa...
10 Jun, 2026, 02.43 PM IST
Consumer staples sector to face growth normalization in 2nd half of 2026, updates on pricing power and channel efficiency eyedConsumer staples growth momentum is likely to moderate in the second half of FY27 as GST-related benefits phase out and high base effects s...
10 Jun, 2026, 02.07 PM IST
CMR Green Tech shares fall 8% after solid 43% stock market debut. Buy, sell or hold?CMR Green Technologies shares fell sharply from their post-listing highs after debuting at a 43% premium to the IPO price. While analysts r...
10 Jun, 2026, 12.01 PM IST
A $6 billion share sale wave in India signals deals perking upIndia's equity markets are poised for a busy period with over $6.3 billion in offerings expected in two months. This surge follows a subdue...
10 Jun, 2026, 08.18 AM IST
With robust GMP, how a little-known aluminium recycling IPO is set for one of strongest listings this yearCMR Green Technologies' IPO is poised for a strong debut, boasting a 36% grey market premium. The aluminium recycling giant saw overwhelmin...
09 Jun, 2026, 10.26 AM IST
CMR Green Technologies IPO allotment today: Check status online as GMP signals 34% listing premiumCMR Green IPO Allotment Status: CMR Green Technologies IPO investors are set to receive allotment updates on June 8 after the Rs 631 crore ...
08 Jun, 2026, 01.15 PM IST
Musk's SpaceX IPO jolts life back into European retail investingEuropean retail investors are eagerly eyeing the SpaceX IPO, with an unusually large allocation planned across several countries. While pla...
06 Jun, 2026, 11.52 AM IST
SoftBank snags Rs 2,873 crore from Lenskart stake sale, clocking 7x returnSVF II Lightbulb Cayman, a SoftBank affiliate, sold 5.65 crore shares, or 3.25%, in Lenskart for Rs 2,873 crore through a block deal on Wed...
04 Jun, 2026, 07.47 PM IST
Global firms exploit India's IPO boom to take profits back to home countriesForeign companies are listing their Indian units to send billions of dollars back home. These are mostly secondary offerings, not for raisi...
04 Jun, 2026, 11.17 AM IST
US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
02 Jun, 2026, 07.31 PM IST